Equity Overview
Price & Market Data
Price: $37.22
Daily Change: $0.00 / 0.00%
Daily Range: $37.22 - $37.22
Market Cap: $2,896,099,584
Daily Volume: 350
Performance Metrics
1 Week: 1.58%
1 Month: 42.71%
3 Months: 61.27%
6 Months: 52.85%
1 Year: 37.85%
YTD: 37.75%
Company Details
Employees: 1611
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.